Yijing He

87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis.

Targeting the β2-adrenergic receptor suppresses melanoma progression by disrupting the PKA-SOX10-MAGEA1 oncogenic axis.

Journal: Biochemical pharmacology

Published: June 15, 2026

ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.

ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function.

Journal: Journal for immunotherapy of cancer

Published: May 24, 2025

TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.

TRPV1 inhibition suppresses non-small cell lung cancer progression by inhibiting tumour growth and enhancing the immune response.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 20, 2023

HLA-DQA1 and DQB1 Alleles are Associated with Acitretin Response in Patients with Psoriasis.

HLA-DQA1 and DQB1 Alleles are Associated with Acitretin Response in Patients with Psoriasis.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 13, 2022

Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity.

Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: February 24, 2022

Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.

Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.

Journal: Therapeutics and clinical risk management

Published: February 18, 2022

Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1.

Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1.

Journal: Translational andrology and urology

Published: February 16, 2022

β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer.

β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer.

Journal: Cell & bioscience

Published: June 23, 2021

Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer.

Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer.

Journal: Frontiers in oncology

Published: November 12, 2020

Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway.

Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8+ T Cells and Inhibiting Tumor AKT/MAPK Pathway.

Journal: Clinical pharmacology and therapeutics

Published: February 20, 2020

Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.

Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.

Journal: International journal of cancer

Published: May 22, 2019

Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria

Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: October 19, 2018

Showing 1-12 of 39

Last Updated: 09/26/2026